In a 63-year-old patient with delayed healing of a pelvic fracture, is it justified to order a DEXA (dual-energy X‑ray absorptiometry) scan?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, ordering a DEXA scan is justified in a 63-year-old with delayed pelvic fracture healing

In a 63-year-old patient presenting with delayed healing of a pelvic fracture, you should order a DEXA scan to evaluate for underlying osteoporosis, as this represents a fragility fracture that warrants bone density assessment regardless of age or sex.

Clinical Rationale

Pelvic Fracture as a Sentinel Event

A pelvic fracture from low-energy trauma in a 63-year-old represents a fragility fracture—a critical indicator of underlying skeletal fragility that demands investigation 1, 2. Recent evidence demonstrates that pelvic fractures carry particularly high odds (OR 3.1) for requiring anti-osteoporotic treatment after DEXA evaluation 1. The delayed healing you're observing further suggests compromised bone quality that needs quantification.

Guideline-Based Indications

The 2025 USPSTF guidelines establish clear screening recommendations 3:

  • Women aged 65+ years: Universal screening recommended
  • Postmenopausal women <65 years with risk factors: Screening recommended using a 2-step approach (risk assessment tool followed by DEXA)
  • Adults with fragility fractures: DEXA indicated regardless of age

Your 63-year-old patient with a pelvic fracture meets criteria through two pathways:

  1. Proximity to age 65 (only 2 years away from universal screening age)
  2. Presence of a fragility fracture (the pelvic fracture itself)

The 2025 European DXA practice guidelines 4 explicitly list "fracture(s) during adulthood (any cause)" as an indication for bone density testing in adults ≥50 years.

Why This Matters for Delayed Healing

Delayed fracture healing in this context likely reflects:

  • Undiagnosed osteoporosis affecting bone regeneration capacity
  • Secondary causes of bone loss that need identification
  • Imminent refracture risk (up to 28% reduction achievable with screening and treatment) 4

The DEXA scan serves multiple purposes here:

  1. Confirms osteoporosis diagnosis (establishes T-score)
  2. Guides treatment decisions for both fracture healing and future fracture prevention
  3. Identifies severity to determine appropriate pharmacotherapy
  4. Provides baseline for monitoring treatment response

Practical Implementation

Order the DEXA scan now with:

  • Hip and lumbar spine imaging (central DEXA is the established standard) 3
  • Vertebral fracture assessment (VFA) if available, given the pelvic fracture history 4
  • Request measurement at contralateral hip if the fractured pelvis interferes with positioning

Concurrent workup while awaiting DEXA:

  • Serum 25-hydroxyvitamin D (vitamin D deficiency increases osteoporosis treatment odds by OR 1.7) 1
  • Calcium, phosphate, alkaline phosphatase
  • TSH, creatinine
  • Complete blood count
  • Consider secondary causes: hyperparathyroidism, hyperthyroidism, celiac disease, multiple myeloma

Common Pitfalls to Avoid

  1. Don't wait until age 65 for screening when a fragility fracture has already occurred—this is a missed opportunity for secondary prevention 2

  2. Don't assume normal bone density based on the patient's age alone—76% of fracture liaison service patients ultimately require treatment after DEXA 1

  3. Don't delay DEXA for "fracture healing first"—the delayed healing itself suggests bone quality issues that need immediate assessment and intervention

  4. Don't order peripheral DEXA or quantitative ultrasound—central DEXA of hip and spine is the only modality validated for treatment decisions 3

Treatment Implications

If DEXA confirms osteoporosis (T-score ≤ -2.5) or even osteopenia (T-score -1.0 to -2.5) in the context of this fragility fracture 4:

  • Initiate bisphosphonate therapy or alternative anti-resorptive agent
  • Optimize vitamin D and calcium supplementation
  • Implement fall prevention strategies
  • Plan repeat DEXA in 1-2 years to monitor treatment response

The orthopedic perspective is crucial here: you are uniquely positioned as the first provider to encounter this patient and initiate comprehensive osteoporosis evaluation 2. Fragility fractures are sentinel events demanding action, not just fracture fixation.

Related Questions

What are the indications for a 64-year-old male to undergo a bone density (dual-energy X-ray absorptiometry) scan?
How should a dual‑energy X‑ray absorptiometry (DEXA) scan be interpreted and when is zoledronic acid indicated?
What are the current guidelines for initiating and repeating DEXA scanning, interpreting T‑scores, and managing osteoporosis, including recommended treatment options and follow‑up intervals?
What are the recommended management steps for a 67-year-old woman with a dual-energy X-ray absorptiometry (DEXA) showing normal lumbar spine and left total hip bone density, osteopenia at the left femoral neck (T-score –1.7) and a 10-year Fracture Risk Assessment (FRAX) of 5.7% for major osteoporotic fracture and 0.8% for hip fracture?
Should a DXA (dual-energy X-ray absorptiometry) bone‑density scan be ordered for all senior patients during routine physical examinations as screening?
What are the symptoms of trichomoniasis in women and men?
Can a patient with a history of macular degeneration safely take Viagra (sildenafil)?
Can bacterial vaginosis, trichomoniasis, or vaginal candidiasis cause hematuria?
How should an umbilical vein varix be evaluated and managed in pregnancy?
For a 75‑year‑old woman taking amlodipine, atenolol, famotidine, empagliflozin (Jardiance), losartan, nifedipine, and rosuvastatin, can I prescribe cetirizine (Zyrtec), topical diclofenac, and a muscle relaxant such as cyclobenzaprine (Flexeril) or metaxalone?
How should I manage a patient with serum iron 35 µg/dL, ferritin 11 µg/L, hemoglobin 9.8 g/dL, reticulocyte count 1.8%, who is taking ferrous sulfate 325 mg and has a poor iron‑rich diet?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.